NEW: No-Cost StreetSmart Live! Events. This type of intellectual capital is usually not made available to the general public. Learn More

Sector Expert: Phillip Seligman

Standard & Poor's



Recent Quotes

"We see growth opportunities for ALGN in emerging markets."

— Phillip Seligman, Standard & Poor's (12/18/12)
more >

"For MDT's FY/13 (April), we expect total sales to rise by 1.9%."

— Phillip Seligman, Standard & Poor's (11/28/12)
more >

"We see growth opportunities for ALGN in emerging markets."

— Phillip Seligman, Standard & Poor's (7/25/12)
more >

"We have upgraded ALGN's rating to Buy based on its promising growth prospects."

— Phillip Seligman, Standard & Poor's (6/23/12)
more >

"We look for ISRG's sales to rise by about 22% in 2012."

— Phillip Seligman, Standard & Poor's (6/23/12)
more >

"We expect ALGN to continue to fuel demand with new products."

— Phillip Seligman, Standard & Poor's (6/16/12)
more >

"We forecast revenue growth of 18% in 2012 for EW."

— Phillip Seligman, Standard & Poor's (5/12/12)
more >

"ISRG's da Vinci system based procedures should grow 25–27% in 2012."

— Phillip Seligman, Standard & Poor's (5/5/12)
more >



Due to permission requirements, not all quotes are shown.